糖尿病肾病的危险因素及其与中医证型的相关性研究
本文选题:糖尿病肾病 切入点:中医证型 出处:《大连医科大学》2016年硕士论文
【摘要】:目的:对大连医科大学附属第二医院住院的2型糖尿病患者及糖尿病肾病(diabetic nephropathy,DN)患者的病历资料进行回顾性分析,研究2型糖尿病患者并发DN的危险因素,并探讨糖尿病肾病中医证型与相关指标之间的内在联系,从而为糖尿病肾病的预防干预提供思路,为糖尿病肾病临床辨证提供参考。方法:随机选择2014年3月到2015年10月在大连医科大学附属第二医院内分泌科、肾内科、中医科确诊为2型糖尿病的患者共183例,其中伴有糖尿病肾病的有96例,分为DN组;不伴有糖尿病肾病的有87例,分为NDN(non diabetic nephropathy)组。将糖尿病肾病患者分为阴虚燥热型、气阴两虚型、脾肾气虚型、阴阳两虚型4个中医证型。对所有患者的性别、年龄、病程、体质指数、血脂(胆固醇、甘油三酯、高密度脂蛋白、低密度脂蛋白)、血压(收缩压、舒张压、脉压差)、血糖(空腹血糖、餐后2h血糖)、糖化血红蛋白、空腹胰岛素、胰岛素敏感指数、胱抑素C、尿蛋白/肌酐比值进行统计。分析2型糖尿病并发DN的危险因素,探讨糖尿病肾病各证型与上述各个指标间的相关性。观察结果用SPSS13.0进行统计学分析,所有计量资料用均数±标准差(sx?)表示,符合正态分布的采用成组t检验,不符合正态分布的采用秩和检验,多组间比较采用方差分析;计数资料以百分率(%)表示,采用χ2卡方检验;用Logistic回归分析分析相关危险因素。结果:1.DN组与NDN组在吸烟史、年龄、病程方面差异具有统计学意义(P0.05),DN组较NDN组吸烟患者更多,年龄更大,病程更长。两组间在性别、饮酒史、糖尿病家族史、体质指数方面差异无统计学意义(P0.05)。2.DN组与NDN组的收缩压、脉压差差异具有统计学意义(P0.05),DN组患者收缩压和脉压差水平高于NDN组;而两组间舒张压、血脂水平差异无统计学意义(P0.05)。3.DN组空腹血糖、空腹胰岛素、胱抑素C水平高于NDN组,DN组胰岛素敏感指数低于NDN组,差异具有统计学意义(P0.05),两组间餐后2h血糖、糖化血红蛋白差异无统计学意义(P0.05)。4.为明确DN发生的相关危险因素,将上述与DN发生具有显著性差异的相关因素进行Logistic回归分析,结果显示:病程(OR=1.083,P=0.006)、胱抑素C(OR=2.427,P=0.037)、空腹血糖(OR=1.131,P=0.011)、空腹胰岛素(OR=1.021,P=0.044)是糖尿病肾病的危险因素。5.DN各证型组间病程、胱抑素C、尿蛋白/肌酐并不完全相等(P0.05),两两比较结果得出,在病程方面,脾肾气虚组和阴阳两虚组均与阴虚燥热组有统计学差异(P0.05),脾肾气虚组和阴阳两虚组患者病程均长于阴虚燥热组患者;阴阳两虚组在胱抑素C和尿蛋白/肌酐方面均较其他三个证型组高,差异有统计学意义(P0.05)。DN各证型组间性别、年龄、BMI、血压、血脂、吸烟史、饮酒史、糖尿病家族史、空腹血糖、餐后2h血糖、糖化血红蛋白、胰岛素敏感指数、胱抑素C、尿蛋白/肌酐比的差异均无统计学意义(P0.05)。结论:1.年龄、病程、吸烟史、收缩压、脉压差、胱抑素C、空腹血糖、空腹胰岛素、胰岛素敏感指数与糖尿病肾病的发病有关,其中病程、空腹血糖、胱抑素C、空腹胰岛素是糖尿病肾病的危险因素。病程越长、空腹血糖越高、空腹胰岛素越高、胱抑素C越高,越容易并发糖尿病肾病。2.病程、胱抑素C、尿蛋白/肌酐与糖尿病肾病的中医分型存在联系:脾肾气虚组和阴阳两虚组患者病程均长于阴虚燥热组患者;阴阳两虚组胱抑素C、尿蛋白/肌酐比值均较其余三个证型组高,提示了阴阳两虚型是糖尿病肾病的终末证型。
[Abstract]:Objective: to patients with type 2 diabetes and diabetic nephropathy in Second Affiliated Hospital of Dalian Medical University (diabetic nephropathy, DN) were analyzed retrospectively. The risk factors of DN in patients with type 2 diabetes mellitus, and to explore the relationship between TCM Syndromes of diabetic nephropathy and related indicators, so as to provide ideas for the prevention and intervention of diabetes mellitus kidney disease, to provide reference for the clinical diagnosis of diabetic nephropathy. Methods: randomly selected from March 2014 to October 2015 in the Second Affiliated Hospital of Dalian Medical University, Department of Endocrinology, Department of traditional Chinese medicine, Department of Nephrology, diagnosed with type 2 diabetes patients with a total of 183 cases with diabetic nephropathy in 96 cases, divided into the DN group; not associated with diabetic nephropathy in 87 cases, divided NDN (non diabetic nephropathy) group. The patients with diabetic nephropathy were divided into yin deficiency, Qi Yin deficiency, spleen qi deficiency, yin and yang two The 4 type of deficiency syndromes. All patients gender, age, duration, body mass index, blood lipids (cholesterol, triglycerides, high density lipoprotein, low density lipoprotein), blood pressure (systolic blood pressure, diastolic blood pressure, pulse pressure), blood glucose (fasting blood glucose, postprandial blood glucose, glycosylated hemoglobin, 2H) fasting insulin, insulin sensitivity index, Cystatin C, urinary protein / creatinine ratio statistics. Analysis of type 2 diabetes risk factors associated with DN, to investigate the correlation between diabetic nephropathy syndrome type with the indexes. Results were statistically analyzed using SPSS13.0 standard deviation for all measurement data (SX?) said that accord with normal distribution using t test, does not meet the normal distribution using the rank sum test, analysis of variance was used to compare between groups; count data by percentage (%), with 2 chi square test; analysis of the related risk factors with Logistic regression analysis. Results: 1.DN group and NDN group in the history of smoking, age, course of disease was statistically significant difference (P0.05), DN group compared with NDN group, smoking patients had more older, longer duration. Between the two groups in gender, drinking history, family history of diabetes, there was no significant difference on body mass index (P0.05) of.2.DN group with the NDN group of systolic blood pressure, pulse pressure difference was statistically significant (P0.05), DN group of patients with systolic pressure and pulse pressure levels higher than the NDN group; and two groups of diastolic pressure, no significant difference of serum lipid levels (P0.05) in group.3.DN, fasting blood glucose, fasting insulin, serum cystatin C levels higher than the NDN group, DN group the insulin sensitivity index was lower than the NDN group, the difference was statistically significant between the two groups (P0.05), 2h postprandial blood glucose, no statistically significant difference in glycated hemoglobin (P0.05) specific.4. related risk factors of DN, DN and the related factors with significant difference Logistic regression analysis results showed that duration (OR=1.083, P=0.006), Cystatin C (OR=2.427, P=0.037), fasting blood glucose (OR=1.131, P=0.011), fasting insulin (OR=1.021, P=0.044).5.DN is a risk factor for diabetic nephropathy syndromes group course of cystatin C, urinary protein / creatinine (P0.05 is not completely equal 22), the results showed that in the course of disease, both spleen and kidney qi deficiency group and Yin and yang deficiency group had significant difference with the two yinxuzaore group (P0.05), spleen and kidney qi deficiency group and Yin and Yang of the two virtual group patients were longer than those of yin asthenia and heat group patients; two of yin and yang deficiency group in cystatin C and urine protein / creatinine compared with other three groups, the difference was statistically significant (P0.05.DN) the syndrome group between gender, age, BMI, blood pressure, blood fat, smoking history, drinking history, family history of diabetes, fasting blood glucose, 2h postprandial blood glucose, glycosylated hemoglobin, insulin sensitive index, inhibition of cystine C, urine protein / creatinine ratio differences were not statistically significant (P0.05). Conclusion: 1. age, disease duration, smoking history, systolic blood pressure, pulse pressure, Cystatin C, fasting blood glucose, fasting insulin, insulin sensitivity index, the incidence of diabetic nephropathy with the course of disease, fasting blood glucose, fasting serum cystatin C insulin is a risk factor for diabetic nephropathy. The longer the duration, the higher the fasting blood glucose, fasting insulin is higher, Cystatin C is higher, more prone to diabetic nephropathy in the course of.2., Cystatin C, urinary protein / creatinine and diabetic nephropathy in TCM are linked: spleen kidney qi deficiency group and Yin and yang deficiency patients were two course longer than yinxuzaore group patients; two of yin and yang deficiency group of cystatin C, urinary protein / creatinine ratio was better than the other three groups, suggesting that the two type is the end of yin and yang deficiency syndrome of diabetic nephropathy.
【学位授予单位】:大连医科大学
【学位级别】:硕士
【学位授予年份】:2016
【分类号】:R259
【相似文献】
相关期刊论文 前10条
1 王玉新,李大启,李公宝,徐琴君;糖尿病肾病患者血清可溶性白细胞介素6受体检测[J];上海免疫学杂志;2001年02期
2 宫雅南,刘冬年,熊玉冰,黄伟文,庄万江;糖尿病足患者糖尿病视网膜病变分析[J];广东医学;2001年06期
3 顾芹,宋守君,李向阳,尤传一;胰激肽原酶肠溶片对早期糖尿病肾病的防治作用[J];中国临床药学杂志;2001年06期
4 曹爱华 ,王瑛 ,李翔;杏丁治疗早期糖尿病肾病疗效观察[J];辽宁实用糖尿病杂志;2001年03期
5 ;中药治疗糖尿病肾病新进展[J];中国中医药信息杂志;2001年04期
6 张桂茹;糖尿病肾病85例临床分析[J];陕西医学杂志;2002年02期
7 侯建明 ,林凤辉 ,张超群;46例2型糖尿病肾病与糖尿病自主神经病变的关系分析[J];福建医药杂志;2002年04期
8 陈文霖;糖尿病饮食[J];医疗保健器具;2002年Z1期
9 孙力,许玲;2型糖尿病患者糖尿病足的危险因素分析[J];山东医药;2002年35期
10 ;糖尿病肾病诊治研究进展[J];基础医学与临床;2003年04期
相关会议论文 前10条
1 张星;许筠;苏建平;张军;程立志;翟晓丽;;糖尿病肾病的临床疗效对比观察[A];第十九次全国中医肾病学术交流会论文汇编[C];2006年
2 杨家茂;;糖尿病肾病防治琐谈[A];全国第二届中医中西医结合肾脏病临床进展学术研讨会论文集[C];2007年
3 丁耀耿;郝桂霞;;糖尿病肾病临床分析[A];全国第二届中医中西医结合肾脏病临床进展学术研讨会论文集[C];2007年
4 张文铠;王志伏;王雪;孙大朋;;糖尿病肾病的治疗现状[A];中华中医药学会第二十一届全国中医肾病学术会议论文汇编(下)[C];2008年
5 倪青;;糖尿病肾病的中西医结合研究[A];第六届全国中西医结合肾脏病学术会议论文汇编[C];2000年
6 孙怡;李健红;宗红燕;;黄芪桂枝五物汤加味治疗糖尿病肾病16例[A];第六届全国中西医结合肾脏病学术会议论文汇编[C];2000年
7 叶军;;糖尿病肾病在儿童时期的早期干预[A];中华医学会第六次全国内分泌学术会议论文汇编[C];2001年
8 杜旭昶;孙志红;闫春芳;刘彩虹;;疏糖丹治疗2型糖尿病50例临床分析[A];第六次中国中西医结合糖尿病学术会议论文汇编[C];2002年
9 于世家;任平;马丽佳;李小娟;郑曙琴;武明东;刘自力;薛丽辉;;糖尿病住院患者1344例回顾性分析[A];第六次中国中西医结合糖尿病学术会议论文汇编[C];2002年
10 郝效槐;魏玫都;崔立俊;;中西并蓄治疗糖尿病肾病[A];第七次中国中西医结合糖尿病学术会议论文汇编[C];2004年
相关重要报纸文章 前10条
1 本报记者 向佳;糖尿病中医药防治项目立足社区[N];中国中医药报;2011年
2 特约记者 鲁海燕;逾八成公众存在糖尿病高危因素[N];家庭医生报;2013年
3 马明愈;现代生活方式导致 糖尿病发病率迅速上升[N];中国妇女报;2005年
4 省立医院内分泌科主任医师 侯建明;糖尿病肾病的防治[N];福建科技报;2004年
5 王文绢 范军星;世界糖尿病日关注焦点:糖尿病并发症[N];健康报;2003年
6 主持人 向红丁博士;糖尿病肾病须早防早治[N];人民政协报;2002年
7 华悦;预防糖尿病,,从减肥开始[N];上海中医药报;2004年
8 刘冬梅;肥胖糖尿病第一诱因[N];天津日报;2004年
9 刘燕玲;首部中医专病指南定下糖尿病治则[N];健康报;2007年
10 崔昕;中药防治糖尿病肾病有进展[N];健康时报;2006年
相关博士学位论文 前10条
1 王晓杰;组蛋白去乙酰化酶4特异性促进糖尿病肾病足细胞损伤[D];山东大学;2015年
2 张永;MiR-346在抗TGF-β信号途径介导的糖尿病肾病发生和发展中的作用机制[D];武汉大学;2015年
3 魏凤江;高尿酸血症、2型糖尿病及糖尿病微血管病变的群体遗传学研究[D];天津医科大学;2015年
4 孙士杰;胱抑素C对2型糖尿病视网膜病变预测价值研究[D];山东大学;2015年
5 魏艳红;PKCα介导的EGFR降解在糖尿病肾病足细胞损伤中的作用及机制[D];华中科技大学;2015年
6 龙泓竹;益气养阴通络散结方防治早期糖尿病肾病的临床及实验研究[D];北京中医药大学;2016年
7 姜e
本文编号:1684355
本文链接:https://www.wllwen.com/zhongyixuelunwen/1684355.html